Dennis Kim
Previously in senior-level clinical and corporate affairs positions at Orexigen Therapeutics, Kim will now lead the businesses clinical development, including clinical and regulatory strategy, trial design and oversight of the company's virtual clinical team.
“An endocrinologist by training, Dennis brings to Zafgen a unique skill set of clinical, regulatory and business development experience in the fields of obesity, endocrinology, diabetes and metabolism,” said Thomas Hughes, president and chief executive officer of Zafgen.